BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 22278433)

  • 21. The d3/fl-GH receptor gene polymorphism does not influence quality of life and body composition in GH-deficient adults receiving GH replacement therapy.
    Adetunji OR; MacFarlane IA; Javadpour M; Alfirevic A; Pirmohamed M; Blair JC
    Eur J Endocrinol; 2009 Oct; 161(4):541-6. PubMed ID: 19605543
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The growth hormone receptor exon 3-deleted/full-length polymorphism and response to growth hormone therapy in prepubertal idiopathic short children.
    Hellgren G; Glad CA; Jonsson B; Johannsson G; Albertsson-Wikland K
    Growth Horm IGF Res; 2015 Jun; 25(3):127-35. PubMed ID: 25742716
    [TBL] [Abstract][Full Text] [Related]  

  • 23. GH responsiveness in a large multinational cohort of SGA children with short stature (NESTEGG) is related to the exon 3 GHR polymorphism.
    Tauber M; Ester W; Auriol F; Molinas C; Fauvel J; Caliebe J; Nugent T; Fryklund L; Ranke MB; Savage MO; Clark AJ; Johnston LB; Hokken-Koelega AC;
    Clin Endocrinol (Oxf); 2007 Sep; 67(3):457-61. PubMed ID: 17555507
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Growth hormone receptor exon 3 isoforms and their implication in growth disorders and treatment.
    Jorge AA; Arnhold IJ
    Horm Res; 2009 Apr; 71 Suppl 2():55-63. PubMed ID: 19407498
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of the exon 3-deleted/full-length growth hormone (GH) receptor polymorphism on the response to GH replacement therapy in adults with severe GH deficiency.
    Barbosa EJ; Palming J; Glad CA; Filipsson H; Koranyi J; Bengtsson BA; Carlsson LM; Boguszewski CL; Johannsson G
    J Clin Endocrinol Metab; 2009 Feb; 94(2):639-44. PubMed ID: 19050057
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exon 3-deleted genotype of growth hormone receptor (GHRd3) positively influences IGF-1 increase at generation test in children with idiopathic short stature.
    Toyoshima MT; Castroneves LA; Costalonga EF; Mendonca BB; Arnhold IJ; Jorge AA
    Clin Endocrinol (Oxf); 2007 Oct; 67(4):500-4. PubMed ID: 17555512
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of the d3-growth hormone (GH) receptor isoform on short-term and long-term treatment response to GH replacement in GH-deficient adults.
    van der Klaauw AA; van der Straaten T; Baak-Pablo R; Biermasz NR; Guchelaar HJ; Pereira AM; Smit JW; Romijn JA
    J Clin Endocrinol Metab; 2008 Jul; 93(7):2828-34. PubMed ID: 18397980
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MECHANISMS IN ENDOCRINOLOGY: Clinical and pharmacogenetic aspects of the growth hormone receptor polymorphism.
    Boguszewski CL; Barbosa EJL; Svensson PA; Johannsson G; Glad CAM
    Eur J Endocrinol; 2017 Dec; 177(6):R309-R321. PubMed ID: 28904008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation between exon 3 polymorphism of growth hormone receptor gene and the responses to rhGH therapy.
    Wei Y; Zheng R; Zhou Y; Wang J; Bao P
    Int J Clin Exp Pathol; 2015; 8(6):7371-7. PubMed ID: 26261638
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Different relationships between the first 2 years on growth hormone treatment and the d3-growth hormone receptor polymorphism in short small-for-gestational-age (SGA) children.
    Dörr HG; Bettendorf M; Hauffa BP; Mehls O; Rohrer T; Stahnke N; Pfäffle R; Ranke MB;
    Clin Endocrinol (Oxf); 2011 Nov; 75(5):656-60. PubMed ID: 21623854
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The distribution of exon 3-deleted/full-length growth hormone receptor polymorphism in the Turkish population.
    Baş F; Keleşoğlu F; Timirci Ö; Kabataş Eryılmaz S; Bozkurt N; Küçükemre Aydın B; Bundak R; Isbir T; Darendeliler F
    J Clin Res Pediatr Endocrinol; 2011; 3(3):126-31. PubMed ID: 21911325
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic Polymorphisms as Predictive Markers of Response to Growth Hormone Therapy in Children with Growth Hormone Deficiency.
    Jung AM; Zenker M; Lißewski C; Schanze D; Wagenpfeil S; Rohrer TR
    Klin Padiatr; 2017 Sep; 229(5):267-273. PubMed ID: 28806841
    [No Abstract]   [Full Text] [Related]  

  • 33. The exon3-deleted growth hormone receptor gene polymorphism (d3-GHR) is associated with insulin and spontaneous growth in short SGA children (NESGAS).
    Wegmann MG; Thankamony A; Roche E; Hoey H; Kirk J; Shaikh G; Ivarsson SA; Söder O; Dunger DB; Juul A; Jensen RB
    Growth Horm IGF Res; 2017 Aug; 35():45-51. PubMed ID: 28719834
    [TBL] [Abstract][Full Text] [Related]  

  • 34. GHR and VDR genes do not contribute to the growth hormone (GH) response in GH deficient and Turner syndrome patients.
    Alvarez-Nava F; Marcano H; Pardo T; Paoli M; Gunczler P; Soto M; Villaloboss J; Lanes R
    J Pediatr Endocrinol Metab; 2010 Aug; 23(8):773-82. PubMed ID: 21073120
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exon 3-deleted/full-length growth hormone receptor polymorphism genotype frequencies in Spanish short small-for-gestational-age (SGA) children and adolescents (n = 247) and in an adult control population (n = 289) show increased fl/fl in short SGA.
    Audí L; Esteban C; Carrascosa A; Espadero R; Pérez-Arroyo A; Arjona R; Clemente M; Wollmann H; Fryklund L; Parodi LA;
    J Clin Endocrinol Metab; 2006 Dec; 91(12):5038-43. PubMed ID: 17003087
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Growth hormone receptor isoforms and fracture risk in adult-onset growth hormone-deficient patients.
    Mormando M; Chiloiro S; Bianchi A; Giampietro A; Angelini F; Tartaglione L; Nasto L; Milardi D; Formenti AM; Giustina A; De Marinis L
    Clin Endocrinol (Oxf); 2016 Nov; 85(5):717-724. PubMed ID: 27437620
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of the (CA)n repeat polymorphism of insulin-like growth factor-I and -202 A/C IGF-binding protein-3 promoter polymorphism with adult height in patients with severe growth hormone deficiency.
    Miletta MC; Scheidegger UA; Giordano M; Bozzola M; Pagani S; Bona G; Dattani M; Hindmarsh PC; Petkovic V; Oser-Meier M; Flück CE; Mullis PE
    Clin Endocrinol (Oxf); 2012 May; 76(5):683-90. PubMed ID: 22026507
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Growth Hormone (GH) receptor C.1319 G>T polymorphism, but not exon 3 retention or deletion is associated with better first-year growth response to GH therapy in patients with GH deficiency.
    Wan L; Chen WC; Tsai Y; Kao YT; Hsieh YY; Lee CC; Tsai CH; Chen CP; Tsai FJ
    Pediatr Res; 2007 Dec; 62(6):735-40. PubMed ID: 17957148
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Short- and long-term responsiveness to low dose growth hormone (GH) in adult GH deficiency: Role of GH receptor polymorphism.
    Bianchi A; Giampietro A; Tartaglione L; Chiloiro S; Gentilella R; Bima C; Anile C; Olivi A; Pontecorvi A; De Marinis L
    J Neuroendocrinol; 2019 Apr; 31(4):e12692. PubMed ID: 30712287
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of the d3-growth hormone receptor (d3-GHR) polymorphism on the therapeutic effect of growth hormone replacement in children with idiopathic growth hormone deficiency in Poland.
    Szmit-Domagalska J; Petriczko E; Drozdzynska M; Adler G; Horodnicka-Jozwa A; Ciechanowicz A; Walczak M
    Neuro Endocrinol Lett; 2016 Sep; 37(4):282-288. PubMed ID: 27857044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.